![]()
duckduckgo | UCB Completes Acquisition of Zogenix, Inc. |
fool | Why Zogenix Stock Is on Fire Today |
investors | Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest |
barrons | Zogenix Stock Rockets on News of Acquisition by UCB |
duckduckgo | Should I Avoid Zogenix, Inc. ? |
yahoo | Zogenix, Inc. : Hedge Funds Are Snapping Up - Yahoo Finance |
fool | 3 Hypergrowth Stocks Expected to Increase Sales 1,185% to 12,629% by 2023 |
nasdaq | 3 “Strong Buy” Stocks That Just Bottomed |
yahoo | Do Hedge Funds Love Zogenix, Inc. ? |
yahoo | Is ZGNX Stock A Buy or Sell? |
yahoo | Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies |
simplywall.st | Read This Before Selling Zogenix, Inc. Shares |
yahoo | Analysts Have Just Cut Their Zogenix, Inc. Revenue Estimates By 0.7% |
yahoo | Does Zogenix's CEO Salary Compare Well With The Performance Of The Company? |
yahoo | These 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts |
zacks | Zogenix Reports Q2 Loss, Misses Revenue Estimates |
yahoo | Did Hedge Funds Make The Right Call On Zogenix, Inc. ? |
gurufocus | Zogenix's Long-Awaited Drug Approved With a Warning |
zacks | Zogenix in Focus: Stock Moves 7.6% Higher |
zacks | Biotech Stock Roundup: GILD Prices Remdesivir, VXRT Rises, ICPT Plunges & More |
yahoo | FOCUS-From Parkinson's to peanut allergy, pandemic puts brakes on new drugs |
smarteranalyst | Zogenix’s Fintepla Gains FDA Approval, but Analyst Sees Challenging Launch Ahead |
marketwatch | Zogenix's shares rise on FDA approval of seizure drug |
zacks | Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment |
yahoo | Zogenix Finally Receives FDA Nod For Fintepla, Analysts Bullish On Outlook |
prnewswire | FDA Approves FINTEPLA® for the Treatment of Seizures Associated with Dravet Syndrome |
in.reuters | FDA approves Zogenix's drug for rare childhood epilepsy |
